TaiMed Biologics Statistics

Total Valuation

TPEX:4147 has a market cap or net worth of TWD 22.01 billion. The enterprise value is 20.88 billion.

Market Cap	22.01B
Enterprise Value	20.88B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4147 has 273.08 million shares outstanding. The number of shares has increased by 6.08% in one year.

Current Share Class	n/a
Shares Outstanding	273.08M
Shares Change (YoY)	+6.08%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	5.39%
Float	185.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.07
PB Ratio	5.47
P/TBV Ratio	6.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-103.46
EV / Sales	34.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-53.87

Financial Position

The company has a current ratio of 25.18, with a Debt / Equity ratio of 0.13.

Current Ratio	25.18
Quick Ratio	13.26
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-1.35
Interest Coverage	-20.01

Financial Efficiency

Return on equity (ROE) is -6.13% and return on invested capital (ROIC) is -4.01%.

Return on Equity (ROE)	-6.13%
Return on Assets (ROA)	-3.55%
Return on Invested Capital (ROIC)	-4.01%
Return on Capital Employed (ROCE)	-5.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	0.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.86% in the last 52 weeks. The beta is 0.21, so TPEX:4147's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-3.86%
50-Day Moving Average	89.92
200-Day Moving Average	84.60
Relative Strength Index (RSI)	44.71
Average Volume (20 Days)	1,061,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4147 had revenue of TWD 610.16 million and -201.83 million in losses. Loss per share was -0.75.

Revenue	610.16M
Gross Profit	211.23M
Operating Income	-252.27M
Pretax Income	-201.83M
Net Income	-201.83M
EBITDA	-104.49M
EBIT	-252.27M
Loss Per Share	-0.75

Full Income Statement

Balance Sheet

The company has 1.65 billion in cash and 522.63 million in debt, giving a net cash position of 1.13 billion or 4.14 per share.

Cash & Cash Equivalents	1.65B
Total Debt	522.63M
Net Cash	1.13B
Net Cash Per Share	4.14
Equity (Book Value)	4.02B
Book Value Per Share	14.73
Working Capital	3.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -379.55 million and capital expenditures -8.06 million, giving a free cash flow of -387.61 million.

Operating Cash Flow	-379.55M
Capital Expenditures	-8.06M
Free Cash Flow	-387.61M
FCF Per Share	-1.42

Full Cash Flow Statement

Margins

Gross margin is 34.62%, with operating and profit margins of -41.34% and -33.08%.

Gross Margin	34.62%
Operating Margin	-41.34%
Pretax Margin	-33.08%
Profit Margin	-33.08%
EBITDA Margin	-17.13%
EBIT Margin	-41.34%
FCF Margin	n/a

Dividends & Yields

TPEX:4147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.08%
Shareholder Yield	-6.08%
Earnings Yield	-0.92%
FCF Yield	-1.76%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4147 has an Altman Z-Score of 14.49.

Altman Z-Score	14.49
Piotroski F-Score	n/a